KLF15, however, is also a key inhibitor of pathological cardiac hypertrophy, and its reduction in hypertrophied hearts and the protective effects of KLF15 overexpression, together with severe stress-induced hypertrophy in KLF15-deficient mice, highlight potential cardiac risks of systemic KLF15 suppression [71]. Here, KLF15 is linked to cardiac hypertrophy.